20 Mar 2024
3m
AstraZeneca: Fusion acquisition will be a cost effective-investment that can improve cancer outcomes
CNBC International Live
Open in Podwise to generate AI notes
Sign in to process this episode and unlock summaries, transcripts, highlights and translations.
Shownotes are not generated by Podwise.